(Q52188560)

26 April 2018

title

Aggregation of amyloid beta-protein as function of age and apolipoprotein E in normal and Alzheimer's serum. (English)

1 reference

26 April 2018

author name string

Chauhan A

1

1 reference

26 April 2018

Pirttilä T

2

1 reference

26 April 2018

Chauhan VP

3

1 reference

26 April 2018

Mehta P

4

1 reference

26 April 2018

Wisniewski HM

5

1 reference

26 April 2018

publication date

1 February 1998

1 reference

26 April 2018

Journal of the Neurological Sciences

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 April 2018

volume

154

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

159-163

1 reference

26 April 2018

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Effect of cerebrospinal fluid from normal and Alzheimer's patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Sequestration of amyloid beta-peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Amyloid beta-peptide is produced by cultured cells during normal metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Possible factors in the etiology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Apolipoprotein E polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Transthyretin sequesters amyloid beta protein and prevents amyloid formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

Alzheimer's disease and soluble A beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900221-9

10.1016/S0022-510X(97)00221-9

7 January 2021

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018